A Meta-Analysis of Cortisol and Cognitive Decline

Read full text Summarise with VIRAT
Authors: Abigail Shell
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cognitive aging refers to expected, gradual declines in several domains of cognition as an individual gets older (i.e., learning and memory, executive function, visuoconstructional-perceptual ability, and complex attention; Salthouse, 2009). Cognitive aging begins, on average, in the late 20s and early 30s when cognitive ability peaks (Salthouse, 2009) and typically occurs at the rate of -0.07 to -0.019 standard deviations a year, varying by age and domain (Hayden et al., 2011; Heiskanen et al., 2024; Salthouse, 2012). However, cognitive aging is heterogenous; there is inter-individual variability in the onset, rate and magnitude of cognitive decline. Individuals who experience accelerated and steeper cognitive declines are at greater risk for earlier cognitive dysfunction and neuropathologies. These neuropathologies include mild cognitive impairment (MCI) and Alzheimer’s Disease and related dementias (ADRDs; Payton et al., 2023). In MCI and ADRDs, cognitive function is one-to-two standard deviations below prior ability (American Psychiatric Association, 2022, pp. 685-686). What remains unclear are the biological mechanisms underlying individual differences in pre-neuropathological trajectories of cognitive decline. As U.S. and global populations continue to age, the prevalence of individuals experiencing cognitive decline, MCI, and ADRDs will continue to rise. Thus, elucidating biological mechanisms that mediate pre-neuropathological trajectories of cognitive decline is critical for public health and for developing risk stratification measures, improving current screening methods, and identifying possible interventions. Cortisol is a hormone secreted by the adrenal gland in response to activation of the hypothalamic-pituitary-adrenal (HPA) axis that plausibly contributes to cognitive decline. Cortisol levels may be influenced by modifiable factors (psychosocial, environmental, and biobehavioral), making it an intervenable biological mechanism of interest. For example, cortisol is secreted in response to stressors, and stress is a modifiable psychosocial factor that has been associated with accelerated cognitive decline (Franks et al., 2023) and risk for ADRDs (Chaudhuri et al., 2025). Cortisol receptors are concentrated in the hippocampus and prefrontal cortex, regions of the brain that subserve learning, memory, and executive function (Lupien et al., 2009). It has been documented within the human literature that administration of glucocorticoids (cortisol and related corticosteroids) and conditions affecting hormone levels within the body impact cognition (Lupien et al., 2007). Cortisol has a U-shaped relationship with memory whereby low- and high-concentrations negatively impact memory and working memory acutely (Lupien et al., 2007; Shields et al., 2015). Thus, during acute timeframes and in conditions affecting circulating levels of cortisol, cortisol has been shown to impact cognition. Cortisol levels have also been shown to associate with neuropathological cognitive decline. Indeed, a 2020 meta-analysis that synthesized literature examining the relationship between cortisol and Alzheimer’s Disease (AD) found that patients with AD had higher morning cortisol levels than controls (Zheng et al., 2020). There is also evidence that total cortisol output is related to increased risk for ADRDs (Ouanes & Popp, 2019). Other studies examine the association of cortisol with pre-neuropathological cognitive aging. Here, findings are more mixed. Many studies find some support for an association of higher levels of cortisol with cognitive decline but there are also null findings (Greendale et al., 2000; Ouanes et al., 2020). This raises the question of whether alterations in cortisol levels influence pre-neuropathological trajectories of cognitive decline. Many factors could impact whether associations are found between cortisol and cognitive decline. These include the type of cortisol measure, quality of the study and of cortisol measures, and age and/or sex of the sample. Cortisol can be measured in saliva, blood, urine, and hair and there are different drawbacks and benefits for each medium. Within saliva and blood, diurnal rhythms of cortisol secretion complicate the reliable assessment of levels. Cortisol levels acutely increase in response to awakening, the cortisol awakening response, and then levels fall over the course of the day. Thus, multiple measurements must be taken to account for or capture these fluctuations. In contrast, urine and hair measures capture accumulated secretion over the sample collection period and diurnal fluctuations do not need to be adjusted for. All these measures capture distinct aspects of HPA activity that might differentially relate to cognitive decline. Additionally, cortisol measures that reflect 24 hours or less of HPA activity reflect state-like differences, rather than trait-like differences (Ross et al., 2014). Thus, studies that measure cortisol over one day or at one timepoint provide less accurate estimates of temporally stable between-individual differences that may be relevant to cognitive decline. There is also evidence that HPA activity differs as a function of age and sex. Older age has found to be associated with flatter diurnal slope and greater cortisol output over the day (Gaffey et al., 2016) and there is evidence that, on average, women have lower circulating levels than men, but this also may be dependent on age and menopausal status (Roelfsema et al., 2017). In summary, cortisol is a hormone that acutely impacts memory and executive function and plausibly relates to cognitive decline. Current evidence is unclear regarding whether alterations in cortisol output and rhythm over the day relates to pre-neuropathological trajectories of decline. Several variables could moderate associations between cortisol and cognitive decline, which could explain some of the inconsistent findings. Thus, the primary aim of the proposed meta-analysis is to examine and summarize the current literature to see if there is an overall association between cortisol and pre-neuropathological trajectories of cognitive decline. Secondary aims will be to investigate what variables might moderate this relationship.

Fields of Study & Subjects

Dementia and Cognitive Impairment Research Stress Responses and Cortisol Menopause: Health Impacts and Treatments

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint